High-intensity focused ultrasound in combination with microbubbles (MBs) is able to inhibit the growth of VX2 rabbit liver tumors in vivo and prolong the survival time of the animals. In this study, we attempt to investigate the feasibility of VX2 tumor growth inhibition using low-frequency ultrasound (US)-mediated MB disruption. Forty-eight New Zealand rabbits with hepatic VX2 tumors were divided into four groups: control, MBs group, low-frequency US group, and US + MB group. The parameters of the US were 20 kHz, 2 W/cm2, 40% duty cycle, 5 min, and once every other day for 2 weeks. At the end of the therapy experiment, 24 rabbits were euthanized, and the cancers were collected and cut into five sections for histological examination, immunohistochemistry, laser confocal microscopy, western blotting assays, and transmission electron microscopy (TEM). Another 24 rabbits were saved, and overall survival time was recorded. The tumor volumes in control, MB, US, and US + MB groups were 6.36 ± 0.58, 5.68 ± 0.42, 5.29 ± 0.26, and 2.04 ± 0.14 cm3, respectively (US + MB versus the other three groups, P < 0.01). Tumor cells manifested coagulation necrosis with internal calcification. Hematoxylin and eosin (H–E) staining revealed interstitial hemorrhage and intravascular thrombosis. The intensity of cyclooxygenase-2 (COX-2), and vascular endothelial growth factor (VEGF) in the US + MB group in the immunohistochemical staining, laser confocal microscopy, and western blotting assays was lower than that of the other three groups (P < 0.05). TEM of the US + MB group revealed vascular endothelial cell wall rupture, widened endothelial cell gaps, interstitial erythrocyte leakage, and microvascular thrombosis, while intact vascular endothelial cells and normal erythrocytes in the tumor vessels were observed in control, MB, and US groups. Rabbits treated with US + MB had a significantly longer overall survival than those in the other three groups (χ2 = 9.328, P = 0.0242). VX2 tumor growth could be inhibited by cavitation induced using low-frequency US and MB.
AlzaraaAGravanteGChungWYAl-LeswasDBrunoMDennisonARLloydDM. Targeted microbubbles in the experimental and clinical setting. Am J Surg2012; 204: 355–66.
2.
YehCK. Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: Current status and future design. Chang Gung Med J2012; 35: 125–39.
3.
GuangYXieLMDingHCaiALHuangY. Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: A meta-analysis. J Cancer Res Clin Oncol2011; 137: 1595–605.
YuanFSankinGZhongP. Dynamics of tandem bubble interaction in a microfluidic channel. J Acoust Soc Am2011; 130: 3339–46.
13.
StrideECoussiosC. Cavitation and contrast: The use of bubbles in ultrasound imaging and therapy. Proc IMechE, Part H: J Engineering in Medicine2010; 224: 171–91.
14.
JamaluddinABallGTuranganCLeightonT. The collapse of single bubbles and approximation of the far-field acoustic emissions for cavitation induced by shock wave lithotripsy. J Fluid Mech2011; 677: 305–41.
15.
CoolSKGeersBLentackerIDe SmedtSCSandersNN. Enhancing nucleic acid delivery with ultrasound and microbubbles. Methods Mol Biol2013; 948: 195–204.
16.
EscoffreJ-MNovellASerrièreSLecomteTBouakazA. Irinotecan delivery by microbubble-assisted ultrasound: In-vitro validation and a pilot preclinical study. Mol Pharm2013; 10: 2667–75..
17.
WangSShinISHancockHJangB-SKimH-SLeeSMZdericVFrenkelVPastanIPaikCH. Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors. J Control Release2012; 162: 218–24.
18.
KrasovitskiBFrenkelVShohamSKimmelE. Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects. Proc Natl Acad Sci USA2011; 108: 3258–63.
19.
DelalandeAPostemaMMignetNMidouxPPichonC. Ultrasound and microbubble-assisted gene delivery: Recent advances and ongoing challenges. Ther Deliv2012; 3: 1199–215.
20.
AhmadiFMcLoughlinIVChauhanSter-HaarG. Bio-effects and safety of low-intensity, low-frequency ultrasonic exposure. Prog Biophys Mol Biol2012; 108: 119–38.
21.
MitragotriS. Healing sound: The use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov2005; 4: 255–60.
22.
ShenZYShenEZhangJZBaiWKWangYYangSLNanSLLinYDLiYHuB. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice. Oncol Rep2013; 30: 842–50.
23.
TodorovaMAgacheVMortazaviOChenBKarshafianRHynynenKManSKerbelRSGoertzDE. Antitumor effects of combining metronomic chemotherapy with the antivascular action of ultrasound stimulated microbubbles. Int J Cancer2013; 132: 2956–66.
24.
ZhouSJLiSWWangJJLiuZJYinGBGongJPLiuCA. High-intensity focused ultrasound combined with herpes simplex virus thymidine kinase gene-loaded ultrasound-targeted microbubbles improved survival of rabbit with VX2 liver tumor. J Gene Med2012; 14: 570–9.
25.
WuFWangZ-BChenW-ZZouJ-ZBaiJZhuHLiK-QJinC-BXieF-LSuH-B. Advanced hepatocellular carcinoma: Treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology2005; 235: 659–67.
26.
UedaHMutohMSekiTKobayashiDMorimotoY. Acoustic cavitation as an enhancing mechanism of low-frequency sonophoresis for transdermal drug delivery. Biol Pharm Bull2009; 32: 916–20.
YuSMKimSJ. Endoplasmic reticulum stress (ER-stress) by 2-deoxy-D-glucose (2DG) reduces cyclooxygenase-2 (COX-2) expression and N-glycosylation and induces a loss of COX-2 activity via a Src kinase-dependent pathway in rabbit articular chondrocytes. Exp Mol Med2010; 42: 777–86.
29.
ForsbergFDickerAPThakurMLRawoolNMLiuJShiWTNazarianLN. Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: Preliminary results. Ultrasound Med Biol2002; 28: 445–51.
30.
KahnETissotNFrerePDauphinABoumhrasMBacheletC-M.FrouinFLizardG. Fluorescence excitation analysis by two-photon confocal laser scanning microscopy: A new method to identify fluorescent nanoparticles on histological tissue sections. Int J Nanomed2012; 7: 5545–54.
31.
FerilLBJrKondoT. Biological effects of low intensity ultrasound: The mechanism involved, and its implications on therapy and on biosafety of ultrasound. J Radiat Res2004; 45: 479–89.
32.
ChenHBraymanAABaileyMRMatulaTJ. Blood vessel rupture by cavitation. Urol Res2010; 38: 321–26.
33.
Chen H, Brayman AA, Bailey MR, Matula TJ. Direct observation of microbubble interactions with ex vivo microvessels. J Acoust Soc Am 2009;125:2680.
BrujanEAMatsumotoY. Collapse of micrometer-sized cavitation bubbles near a rigid boundary. Microfluidics Nanofluidics2012; 13: 957–66.
36.
PainAHui Terence GohBKlaseboerEOhlSWCheong KhooB. Jets in quiescent bubbles caused by a nearby oscillating bubble. J Appl Phys2012; 111: 054912–9.
37.
CravottoGGaudinoECCintasP. On the mechanochemical activation by ultrasound. Chem Soc Rev2013; 42: 7521–34.
38.
Gao Y, Gao S, Zhao B, Zhao Y, Hua X, Tan K, Liu Z. Vascular effects of microbubble-enhanced, pulsed, focused ultrasound on liver blood perfusion. Ultrasound Med Biol 2012;38:91–8.
39.
TinkovSBekeredjianRWinterGCoesterC. Microbubbles as ultrasound triggered drug carriers. J Pharm Sci2009; 98: 1935–61.
40.
ChenHKreiderWBraymanAABaileyMRMatulaTJ. Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett2011; 106: 34301–34301.
41.
Suslick KS, Flannigan DJ. Inside a collapsing bubble: sonoluminescence and the conditions during cavitation. Annu Rev Phys Chem 2008;59:659–83.
42.
HollandCKApfelRE. An improved theory for the prediction of microcavitation thresholds. IEEE Trans Ultrason Ferroelectr Freq Control1989; 36: 204–8.
43.
BastaGVenneriLLazzeriniGPasanisiEPianelliMVesentiniNDel TurcoSKusmicCPicanoE. In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound. Cardiovasc Res2003; 58: 156–61.
44.
LiuZGaoSZhaoYLiPLiuJTanKXieF. Disruption of tumor neovasculature by microbubble enhanced ultrasound: A potential new physical therapy of anti-angiogenesis. Ultrasound Med Biol2011; 38: 253–61.
45.
Ş ahinMŞ ahinEGümüş lüS. Cyclooxygenase-2 in cancer and angiogenesis. Angiology2009; 60: 242–53.
46.
ZhangJYeJMaDLiuNWuHYuSSunXTseWJiC. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway. Carcinogenesis2013; 34: 667–77.
47.
ChenLLiNYeH. The effect of high intensity focused ultrasound on vascular endothelial growth factor and microvessel density in rabbit V-X2 hepatocellular carcinoma models. Hepatogastroenterology2013; 60: 136–9.
48.
DimmelerSZeiherAM. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res2000; 87: 434–9.
49.
HwangJHBraymanAAReidyMAMatulaTJKimmeyMBCrumLA. Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo. Ultrasound Med Biol2005; 31: 553–64.
